Health guideFull evidence and safety review • 24 August 2026
01 — WHAT SHINGLES IS
Varicella-zoster virus reactivates along a nerve
After chickenpox, varicella-zoster virus remains inactive in sensory nerves and may reactivate years later as shingles. The usual pattern is pain, tingling, itching or sensitivity followed by grouped blisters in a band on one side of the body or face. Risk and complications rise with age and immune suppression.
Shingles is not caused by recent contact with someone who has shingles. A person with active blisters can transmit virus to a susceptible person, causing chickenpox—not shingles.
02 — RECOGNITION AND DIAGNOSIS
Pain may begin before the rash
Burning, stabbing or skin sensitivity can precede lesions by days. The rash usually does not cross the midline. Diagnosis is often clinical; swab testing can help with unusual, mild, widespread or immunocompromised presentations. Herpes simplex, contact dermatitis, insect bites and bacterial infection can mimic it.
Pain without rash is difficult to diagnose and should not be labeled shingles automatically. Chest, abdominal, dental or neurological disease may require evaluation.
03 — URGENT PATTERNS
Same-day assessment mattersSeek urgent care for rash or pain near the eye, on the nose tip or forehead; new vision change; facial weakness; ear blisters with hearing or balance symptoms; widespread lesions; severe headache, confusion or weakness; pregnancy exposure concerns; or shingles in a person with major immune suppression.
Eye involvement can threaten vision even before obvious eye redness. Disseminated infection can affect internal organs and may require hospital intravenous treatment.
04 — ANTIVIRAL TREATMENT
Start promptly, especially when complication risk is high
Acyclovir, valacyclovir or famciclovir can shorten viral activity and are most effective when started early, commonly within 72 hours of rash onset. Treatment may still be considered later when new lesions continue, pain is severe, the face or eye is involved, or immunity is impaired.
Dose and drug depend on kidney function, age, interactions and severity. Hydration and renal review matter. Antivirals do not instantly remove pain and do not replace urgent ophthalmic care.
05 — SKIN AND ACUTE PAIN CARE
Protect skin while controlling pain safely
Keep lesions clean and dry, wear loose clothing, use cool compresses and avoid scratching. Cover weeping lesions when around others. Seek review for spreading redness, pus, fever or rapidly worsening swelling.
Acetaminophen or selected anti-inflammatory medicines may help according to individual liver, kidney, bleeding and cardiovascular risk. Severe neuropathic pain may require prescription treatment. Opioids, when used at all, need a short, monitored plan.
06 — POSTHERPETIC NEURALGIA
Nerve pain can persist after the skin heals
Postherpetic neuralgia may cause burning, electric pain, itching or pain from light touch. Risk rises with age, severe acute pain and extensive rash. Options include topical lidocaine or capsaicin and selected medicines such as gabapentin, pregabalin or tricyclic antidepressants. Each carries sedation, falls, cognitive, cardiac or interaction risks.
Set goals around sleep, clothing tolerance and function. Persistent pain deserves reassessment rather than repeated antibiotics or unverified antivirals.
07 — PROTECTING OTHERS
Blisters are infectious until crusted
Cover the rash, wash hands and avoid touching lesions. Until all lesions crust, avoid close contact with pregnant people lacking immunity, premature infants and people with weakened immune systems. Do not share towels.
Airborne precautions may be needed for widespread disease or immune suppression in healthcare settings. Follow local infection-control advice.
08 — VACCINATION
Vaccination prevents shingles and its complications
CDC ↗ recommends two doses of recombinant zoster vaccine for adults 50 and older and for younger adults with specified immune compromise. Previous shingles does not guarantee protection from recurrence. Timing after an acute episode and around immune-suppressing therapy should be planned clinically.
The vaccine cannot treat an active episode. Sore arm, fatigue, muscle pain, headache, fever and gastrointestinal symptoms commonly last a few days. Product recommendations vary by country.
09 — NATURAL AND COMPLEMENTARY CLAIMS
No topical oil or supplement replaces antiviral assessment
Oatmeal baths or cool compresses may soothe intact skin, but essential oils, bleach, acids and irritating pastes can worsen injury. There is no established herb that clears varicella-zoster virus or prevents postherpetic neuralgia.
St. John’s wort interacts with many medicines. High-dose vitamins and immune boosters are not proven treatments and may be risky with cancer, transplant or autoimmune therapy.
10 — PRACTICAL PLAN
- Record onset.Note when pain and the first lesions appeared.
- Check location and immunity.Face, eye, ear, widespread rash or immune suppression raises urgency.
- Seek antiviral review.Do not wait for every blister to appear.
- Protect skin and contacts.Cover lesions and avoid high-risk susceptible people until crusted.
- Treat pain early.Use a risk-appropriate acute plan and reassess persistent nerve pain.
- Plan vaccination.Discuss the two-dose schedule after recovery.